Clinical Trial Update: N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating whether N-acetylcysteine can protect pulpal stem cells during endodontic revascularization; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endodontic Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Endodontic Disease | EARLY_Phase 1 | Status: TERMINATED